{"id":343811,"date":"2026-11-11T13:23:17","date_gmt":"2026-11-11T07:53:17","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=343811"},"modified":"2026-11-11T13:23:17","modified_gmt":"2026-11-11T07:53:17","slug":"twenty-five-percent-quarterly-revenue-growth-stocks-to-buy","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/","title":{"rendered":"25 Percent Quarterly Revenue Growth Stocks to Buy in November 2026: 5 Names on the Watchlist"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>BoM Rs 87.68. Cholamandalam Rs 1,791. Divi&#8217;s Labs Rs 11,566. KFin Technologies Rs 914.50. Uno Minda Rs 1,354. NSE closing prices, 9 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Five 25 percent quarterly revenue growth stocks to buy on the November 2026 watchlist are Bank of Maharashtra, Cholamandalam Investment and Finance, Divi&#8217;s Laboratories, KFin Technologies and Uno Minda. All five grew revenue in their latest full year, and all five also grew net profit. Bank of Maharashtra has both the lowest P\/E at 7.77 and the highest return on equity at 22.53%. Check each valuation against your own risk appetite before acting.<\/p>\n<\/p><\/div>\n<p>The 25 percent quarterly revenue growth stocks to buy in November 2026 start with five listed names: Bank of Maharashtra, Cholamandalam Investment and Finance, Divi&#8217;s Laboratories, KFin Technologies and Uno Minda. These five companies each grew revenue by about 22% to 28% in the September 2026 quarter compared with a year earlier. Divi&#8217;s Laboratories is part of the <a href=\"https:\/\/univest.in\/indices\/nifty-pharma\/nifty-pharma-share-price-today\">Nifty Pharma<\/a> index.<\/p>\n<p>This article ranks none of them as a sure thing. It lays out the numbers each company has reported, how the shares are priced today and what an investor should check before adding any of these 25 percent quarterly revenue growth stocks to buy to a portfolio. All prices are NSE closing prices of 9 November 2026, and financials come from company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#Which_Are_the_Best_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy_in_November_2026\" title=\"Which Are the Best 25 Percent Quarterly Revenue Growth Stocks to Buy in November 2026?\">Which Are the Best 25 Percent Quarterly Revenue Growth Stocks to Buy in November 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#Why_These_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy_Are_in_Focus\" title=\"Why These 25 Percent Quarterly Revenue Growth Stocks to Buy Are in Focus\">Why These 25 Percent Quarterly Revenue Growth Stocks to Buy Are in Focus<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#Bank_of_Maharashtra_The_Growing_Public_Sector_Bank_Among_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy\" title=\"Bank of Maharashtra: The Growing Public Sector Bank Among 25 Percent Quarterly Revenue Growth Stocks to Buy\">Bank of Maharashtra: The Growing Public Sector Bank Among 25 Percent Quarterly Revenue Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#Cholamandalam_Investment_and_Finance_The_Vehicle_Finance_Specialist_Among_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy\" title=\"Cholamandalam Investment and Finance: The Vehicle Finance Specialist Among 25 Percent Quarterly Revenue Growth Stocks to Buy\">Cholamandalam Investment and Finance: The Vehicle Finance Specialist Among 25 Percent Quarterly Revenue Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#Divis_Laboratories_The_API_Specialist_Among_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy\" title=\"Divi&#8217;s Laboratories: The API Specialist Among 25 Percent Quarterly Revenue Growth Stocks to Buy\">Divi&#8217;s Laboratories: The API Specialist Among 25 Percent Quarterly Revenue Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#KFin_Technologies_The_Registrar_and_Technology_Name_Among_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy\" title=\"KFin Technologies: The Registrar and Technology Name Among 25 Percent Quarterly Revenue Growth Stocks to Buy\">KFin Technologies: The Registrar and Technology Name Among 25 Percent Quarterly Revenue Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#Uno_Minda_The_Component_Supplier_Among_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy\" title=\"Uno Minda: The Component Supplier Among 25 Percent Quarterly Revenue Growth Stocks to Buy\">Uno Minda: The Component Supplier Among 25 Percent Quarterly Revenue Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#Growth_Snapshot_Latest_Full_Year_and_Latest_Quarter\" title=\"Growth Snapshot: Latest Full Year and Latest Quarter\">Growth Snapshot: Latest Full Year and Latest Quarter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#Factors_That_Move_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy\" title=\"Factors That Move 25 Percent Quarterly Revenue Growth Stocks to Buy\">Factors That Move 25 Percent Quarterly Revenue Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#Risks_to_Keep_in_Mind_Before_Buying_25_Percent_Quarterly_Revenue_Growth_Stocks\" title=\"Risks to Keep in Mind Before Buying 25 Percent Quarterly Revenue Growth Stocks\">Risks to Keep in Mind Before Buying 25 Percent Quarterly Revenue Growth Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#How_to_Choose_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy\" title=\"How to Choose 25 Percent Quarterly Revenue Growth Stocks to Buy\">How to Choose 25 Percent Quarterly Revenue Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#How_to_Invest_in_25_Percent_Quarterly_Revenue_Growth_Stocks\" title=\"How to Invest in 25 Percent Quarterly Revenue Growth Stocks\">How to Invest in 25 Percent Quarterly Revenue Growth Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#Frequently_Asked_Questions_on_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy\" title=\"Frequently Asked Questions on 25 Percent Quarterly Revenue Growth Stocks to Buy\">Frequently Asked Questions on 25 Percent Quarterly Revenue Growth Stocks to Buy<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#Which_are_the_best_25_percent_quarterly_revenue_growth_stocks_to_buy_in_November_2026\" title=\"Which are the best 25 percent quarterly revenue growth stocks to buy in November 2026?\">Which are the best 25 percent quarterly revenue growth stocks to buy in November 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#Is_Divis_Laboratories_a_good_stock_to_buy_from_this_25_Percent_Quarterly_Revenue_Growth_list\" title=\"Is Divi&#8217;s Laboratories a good stock to buy from this 25 Percent Quarterly Revenue Growth list?\">Is Divi&#8217;s Laboratories a good stock to buy from this 25 Percent Quarterly Revenue Growth list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#Are_these_25_percent_quarterly_revenue_growth_stocks_expensive_right_now\" title=\"Are these 25 percent quarterly revenue growth stocks expensive right now?\">Are these 25 percent quarterly revenue growth stocks expensive right now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#Which_of_these_25_percent_quarterly_revenue_growth_stocks_pay_a_dividend\" title=\"Which of these 25 percent quarterly revenue growth stocks pay a dividend?\">Which of these 25 percent quarterly revenue growth stocks pay a dividend?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#Which_stock_on_this_list_has_the_highest_return_on_equity\" title=\"Which stock on this list has the highest return on equity?\">Which stock on this list has the highest return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#What_are_the_risks_of_investing_in_25_percent_quarterly_revenue_growth_stocks\" title=\"What are the risks of investing in 25 percent quarterly revenue growth stocks?\">What are the risks of investing in 25 percent quarterly revenue growth stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/twenty-five-percent-quarterly-revenue-growth-stocks-to-buy\/#How_can_I_invest_in_25_percent_quarterly_revenue_growth_stocks_in_India\" title=\"How can I invest in 25 percent quarterly revenue growth stocks in India?\">How can I invest in 25 percent quarterly revenue growth stocks in India?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Which_Are_the_Best_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy_in_November_2026\"><\/span><strong>Which Are the Best 25 Percent Quarterly Revenue Growth Stocks to Buy in November 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The best 25 percent quarterly revenue growth stocks to buy in November 2026 for a watchlist are Bank of Maharashtra, Cholamandalam Investment and Finance, Divi&#8217;s Laboratories, KFin Technologies and Uno Minda. They were picked because each has complete reported financials, profit in the latest quarter and an NSE listing. The table puts their market data side by side.<\/p>\n<table style=\"border-collapse:collapse;width:100%;\" border=\"1\" cellpadding=\"6\">\n<thead>\n<tr>\n<th>Company<\/th>\n<th>CMP (Rs)<\/th>\n<th>Market Cap<\/th>\n<th>P\/E<\/th>\n<th>ROE<\/th>\n<th>Dividend Yield<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Bank of Maharashtra<\/td>\n<td>87.68<\/td>\n<td>Rs 62,225 crore<\/td>\n<td>7.77<\/td>\n<td>22.53%<\/td>\n<td>1.48%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/cholafin\/cholamandalam-investment-and-finance-company-ltd-share-price-today\">Cholamandalam Investment and Finance<\/a><\/td>\n<td>1,791<\/td>\n<td>Rs 1,37,140 crore<\/td>\n<td>22.04<\/td>\n<td>18.02%<\/td>\n<td>0.12%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi's-laboratories-ltd-share-price-today\">Divi&#8217;s Laboratories<\/a><\/td>\n<td>11,566<\/td>\n<td>Rs 2,56,310 crore<\/td>\n<td>87.63<\/td>\n<td>15.32%<\/td>\n<td>0.31%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/kfintech\/kfin-technologies-ltd-share-price-today\">KFin Technologies<\/a><\/td>\n<td>914.50<\/td>\n<td>Rs 14,910 crore<\/td>\n<td>42.76<\/td>\n<td>21.47%<\/td>\n<td>1.39%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/unominda\/uno-minda-ltd-share-price-today\">Uno Minda<\/a><\/td>\n<td>1,354<\/td>\n<td>Rs 63,290 crore<\/td>\n<td>49.04<\/td>\n<td>17.53%<\/td>\n<td>0.24%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>On valuation, Bank of Maharashtra trades below the industry P\/E; KFin Technologies sits close to it; Cholamandalam Investment and Finance, Divi&#8217;s Laboratories and Uno Minda carry a premium. Valuation is the first filter for any 25 percent quarterly revenue growth stocks to buy list, and it is covered again in the risk section.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_These_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy_Are_in_Focus\"><\/span><strong>Why These 25 Percent Quarterly Revenue Growth Stocks to Buy Are in Focus<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>In this list, FY26 net profit and revenue both grew for every company, and quarterly profit in the September 2026 quarter was higher than a year earlier for all five. The list covers a public sector bank, a vehicle finance company, a pharma ingredients maker, a registrar for mutual funds and an auto components maker. Investors comparing the best stocks with 25 percent quarterly revenue growth in India usually check whether sales growth turns into profit, how the shares are valued and how much debt the company carries.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bank_of_Maharashtra_The_Growing_Public_Sector_Bank_Among_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy\"><\/span><strong>Bank of Maharashtra: The Growing Public Sector Bank Among 25 Percent Quarterly Revenue Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bank of Maharashtra is a public sector bank with a strong presence in Maharashtra and a growing loan book. The stock trades at Rs 87.68 with a market capitalisation of Rs 62,225 crore and a P\/E of 7.77, against an industry P\/E of 11.45.<\/p>\n<p>FY26 revenue rose 15.6% to Rs 32,824 crore and net profit rose 26.6% to Rs 7,017 crore. In the September 2026 quarter, revenue grew 22.1% year on year to Rs 9,736 crore, while net profit grew 41.4% to Rs 2,310 crore.<\/p>\n<p>Return on equity is 22.53%, and the dividend yield is 1.48%. Promoters hold 73.60%, foreign institutions 6.51% and domestic institutions 13.77% as of September 2026. Domestic institutional holding has risen from 10.05% to 13.77% over the last year.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Cholamandalam_Investment_and_Finance_The_Vehicle_Finance_Specialist_Among_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy\"><\/span><strong>Cholamandalam Investment and Finance: The Vehicle Finance Specialist Among 25 Percent Quarterly Revenue Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Cholamandalam Investment and Finance is a vehicle finance, home loan and small business lender in the Murugappa Group. At Rs 1,791, the stock has a market capitalisation of Rs 1,37,140 crore and trades at 22.04 times earnings, while the industry P\/E is 16.15.<\/p>\n<p>Reported numbers show FY26 revenue of Rs 31,539 crore, up 20.6% year on year, with net profit at Rs 5,229 crore, up 22.7%. The September 2026 quarter added revenue of Rs 9,395 crore (up 23.4%) and net profit of Rs 1,630 crore (up 40.6%).<\/p>\n<p>Return on equity is 18.02%, and the dividend yield is 0.12%. Promoters hold 48.93%, foreign institutions 24.87% and domestic institutions 20.38% as of September 2026. Domestic institutional holding has risen from 17.27% to 20.38% over the last year.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check 25 Percent Quarterly Revenue Growth Stocks Live on the Univest Screener<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Divis_Laboratories_The_API_Specialist_Among_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy\"><\/span><strong>Divi&#8217;s Laboratories: The API Specialist Among 25 Percent Quarterly Revenue Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Divi&#8217;s Laboratories is a contract manufacturer of active pharmaceutical ingredients and intermediates for global drug makers. Its market capitalisation is Rs 2,56,310 crore, the share price is Rs 11,566 and the P\/E of 87.63 compares with an industry P\/E of 37.65.<\/p>\n<p>Over FY26, net profit rose 17.2% to Rs 2,568 crore on revenue of Rs 11,067 crore, which was up 14.0%. The latest quarter, the June 2026 quarter, brought revenue of Rs 3,144 crore, up 24.3% year on year, and net profit of Rs 902 crore, up 65.5%.<\/p>\n<p>Return on equity is 15.32%, debt-to-equity is 0.00, and the dividend yield is 0.31%. Promoters hold 51.88%, foreign institutions 20.38% and domestic institutions 19.17% as of September 2026. A point to keep in view: at a P\/E of 87.63, expectations are already high.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"KFin_Technologies_The_Registrar_and_Technology_Name_Among_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy\"><\/span><strong>KFin Technologies: The Registrar and Technology Name Among 25 Percent Quarterly Revenue Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>KFin Technologies is a registrar and technology services company for mutual funds and issuers. The stock trades at Rs 914.50 with a market capitalisation of Rs 14,910 crore and a P\/E of 42.76, against an industry P\/E of 42.66.<\/p>\n<p>FY26 revenue rose 19.1% to Rs 1,344 crore and net profit rose 3.3% to Rs 344 crore. In the September 2026 quarter, revenue grew 28.1% year on year to Rs 410 crore, while net profit grew 7.5% to Rs 100 crore.<\/p>\n<p>Return on equity is 21.47%, and the dividend yield is 1.39%. Promoters hold 14.06%, foreign institutions 20.07% and domestic institutions 37.55% as of September 2026. Domestic institutional holding has risen from 24.80% to 37.55% over the last year.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Uno_Minda_The_Component_Supplier_Among_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy\"><\/span><strong>Uno Minda: The Component Supplier Among 25 Percent Quarterly Revenue Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Uno Minda is a component supplier with electronics and EV-related products. At Rs 1,354, the stock has a market capitalisation of Rs 63,290 crore and trades at 49.04 times earnings, while the industry P\/E is 36.13.<\/p>\n<p>Reported numbers show FY26 revenue of Rs 19,692 crore, up 17.2% year on year, with net profit at Rs 1,284 crore, up 25.8%. The June 2026 quarter added revenue of Rs 5,563 crore (up 23.6%) and net profit of Rs 316 crore (up 2.1%).<\/p>\n<p>Return on equity is 17.53%, debt-to-equity is 0.40, and the dividend yield is 0.24%. Promoters hold 68.36%, foreign institutions 8.78% and domestic institutions 17.11% as of September 2026. Domestic institutional holding has risen from 15.80% to 17.11% over the last year.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track these 25 percent quarterly revenue growth stocks live and get daily stock recommendations.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Growth_Snapshot_Latest_Full_Year_and_Latest_Quarter\"><\/span><strong>Growth Snapshot: Latest Full Year and Latest Quarter<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares year-on-year growth in revenue and net profit for all five 25 percent quarterly revenue growth stocks, using filed results.<\/p>\n<table style=\"border-collapse:collapse;width:100%;\" border=\"1\" cellpadding=\"6\">\n<thead>\n<tr>\n<th>Company<\/th>\n<th>Full-Year Revenue Growth<\/th>\n<th>Full-Year Profit Growth<\/th>\n<th>Latest Quarter<\/th>\n<th>Quarter Revenue Growth<\/th>\n<th>Quarter Profit Growth<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Bank of Maharashtra<\/td>\n<td>15.6%<\/td>\n<td>26.6%<\/td>\n<td>Sep 2026<\/td>\n<td>22.1%<\/td>\n<td>41.4%<\/td>\n<\/tr>\n<tr>\n<td>Cholamandalam Investment and Finance<\/td>\n<td>20.6%<\/td>\n<td>22.7%<\/td>\n<td>Sep 2026<\/td>\n<td>23.4%<\/td>\n<td>40.6%<\/td>\n<\/tr>\n<tr>\n<td>Divi&#8217;s Laboratories<\/td>\n<td>14.0%<\/td>\n<td>17.2%<\/td>\n<td>Jun 2026<\/td>\n<td>24.3%<\/td>\n<td>65.5%<\/td>\n<\/tr>\n<tr>\n<td>KFin Technologies<\/td>\n<td>19.1%<\/td>\n<td>3.3%<\/td>\n<td>Sep 2026<\/td>\n<td>28.1%<\/td>\n<td>7.5%<\/td>\n<\/tr>\n<tr>\n<td>Uno Minda<\/td>\n<td>17.2%<\/td>\n<td>25.8%<\/td>\n<td>Jun 2026<\/td>\n<td>23.6%<\/td>\n<td>2.1%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Factors_That_Move_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy\"><\/span><strong>Factors That Move 25 Percent Quarterly Revenue Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Four factors tend to drive 25 percent quarterly revenue growth stocks, and each one is worth checking before a purchase.<\/p>\n<ul>\n<li><strong>Quarterly growth:<\/strong> Revenue rose about 22% to 28% year on year.<\/li>\n<li><strong>Dividends:<\/strong> Bank of Maharashtra yields about 1.5%.<\/li>\n<li><strong>Return on equity:<\/strong> Bank of Maharashtra leads at about 23%.<\/li>\n<li><strong>Valuation:<\/strong> P\/E runs from about 8 to 88.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Keep_in_Mind_Before_Buying_25_Percent_Quarterly_Revenue_Growth_Stocks\"><\/span><strong>Risks to Keep in Mind Before Buying 25 Percent Quarterly Revenue Growth Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The first risk is that Divi&#8217;s Laboratories trades at a P\/E near 88 while Bank of Maharashtra trades near 8, so expectations differ widely. The second is that Cholamandalam Investment and Finance carries the highest borrowings of the five as a lender. Check results every quarter.<\/p>\n<p>On the numbers, Divi&#8217;s Laboratories trades at the highest P\/E on this list at 87.63, so its earnings need to keep growing to support the price. 25 Percent Quarterly Revenue Growth stocks to buy can still fall when markets turn weak, and a staggered entry has historically suited investors better than a lump-sum purchase.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy\"><\/span><strong>How to Choose 25 Percent Quarterly Revenue Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Compare growth:<\/strong> Bank of Maharashtra grew FY26 profit most, by about 27%.<\/li>\n<li><strong>Check P\/E:<\/strong> Bank of Maharashtra trades lowest.<\/li>\n<li><strong>Read ROE:<\/strong> Bank of Maharashtra leads.<\/li>\n<li><strong>Spread sectors:<\/strong> Mix banking, lending, pharma, market services and auto parts.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_25_Percent_Quarterly_Revenue_Growth_Stocks\"><\/span><strong>How to Invest in 25 Percent Quarterly Revenue Growth Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ol>\n<li>Shortlist two or three companies from this list that match your risk appetite.<\/li>\n<li>Open the Univest Screener and compare P\/E, ROE and debt for each stock.<\/li>\n<li>Check the latest quarterly results and shareholding pattern on NSE or BSE.<\/li>\n<li>Decide an amount you can hold for three to five years and split it into two or three purchases.<\/li>\n<li>Review the holding after every quarterly result instead of reacting to daily price moves.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bank of Maharashtra offers both the lowest P\/E on this list at 7.77 and the highest return on equity at 22.53%, and Bank of Maharashtra posted the fastest net profit growth in its latest full year at 26.6%. Among the best 25 percent quarterly revenue growth stocks in India, these five give investors a spread of size, valuation and growth, so the right pick depends on risk appetite and holding period. Spread the entry, keep position sizes sensible and consult a SEBI-registered advisor before investing in any of these 25 percent quarterly revenue growth stocks to buy.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_25_Percent_Quarterly_Revenue_Growth_Stocks_to_Buy\"><\/span><strong>Frequently Asked Questions on 25 Percent Quarterly Revenue Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_25_percent_quarterly_revenue_growth_stocks_to_buy_in_November_2026\"><\/span><strong>Which are the best 25 percent quarterly revenue growth stocks to buy in November 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The five 25 percent quarterly revenue growth stocks on the November 2026 watchlist are Bank of Maharashtra, Cholamandalam Investment and Finance, Divi&#8217;s Laboratories, KFin Technologies and Uno Minda. Bank of Maharashtra has both the lowest P\/E at 7.77 and the highest ROE at 22.53%, and Bank of Maharashtra grew net profit 26.6% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Divis_Laboratories_a_good_stock_to_buy_from_this_25_Percent_Quarterly_Revenue_Growth_list\"><\/span><strong>Is Divi&#8217;s Laboratories a good stock to buy from this 25 Percent Quarterly Revenue Growth list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Divi&#8217;s Laboratories is the largest company on this list with a market capitalisation of Rs 2,56,310 crore and a P\/E of 87.63 against an industry P\/E of 37.65. Its FY26 revenue rose 14.0% and net profit rose 17.2%, with return on equity at 15.32%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_these_25_percent_quarterly_revenue_growth_stocks_expensive_right_now\"><\/span><strong>Are these 25 percent quarterly revenue growth stocks expensive right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Valuations vary across the group. Bank of Maharashtra trades at a P\/E of 7.77, Cholamandalam Investment and Finance trades at a P\/E of 22.04, Divi&#8217;s Laboratories trades at a P\/E of 87.63, KFin Technologies trades at a P\/E of 42.76, Uno Minda trades at a P\/E of 49.04, against industry multiples ranging from 11.45 to 42.66. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_25_percent_quarterly_revenue_growth_stocks_pay_a_dividend\"><\/span><strong>Which of these 25 percent quarterly revenue growth stocks pay a dividend?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dividend yields on this list are Bank of Maharashtra 1.48%, Cholamandalam Investment and Finance 0.12%, Divi&#8217;s Laboratories 0.31%, KFin Technologies 1.39%, Uno Minda 0.24%. Yields are modest across the group, so most investors look at these stocks for growth in earnings rather than for income, and payouts can change with company profits.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_stock_on_this_list_has_the_highest_return_on_equity\"><\/span><strong>Which stock on this list has the highest return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bank of Maharashtra has the highest ROE on this list at 22.53%, followed by KFin Technologies at 21.47% and Cholamandalam Investment and Finance at 18.02%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_25_percent_quarterly_revenue_growth_stocks\"><\/span><strong>What are the risks of investing in 25 percent quarterly revenue growth stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are funding costs at the lender, one very high valuation and asset quality at the bank. On this list, Divi&#8217;s Laboratories trades at the highest P\/E of 87.63, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_invest_in_25_percent_quarterly_revenue_growth_stocks_in_India\"><\/span><strong>How can I invest in 25 percent quarterly revenue growth stocks in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P\/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best 25 percent quarterly revenue growth stocks to buy in November 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The five 25 percent quarterly revenue growth stocks on the November 2026 watchlist are Bank of Maharashtra, Cholamandalam Investment and Finance, Divi's Laboratories, KFin Technologies and Uno Minda. Bank of Maharashtra has both the lowest P\/E at 7.77 and the highest ROE at 22.53%, and Bank of Maharashtra grew net profit 26.6% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.\"}},{\"@type\":\"Question\",\"name\":\"Is Divi's Laboratories a good stock to buy from this 25 Percent Quarterly Revenue Growth list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Divi's Laboratories is the largest company on this list with a market capitalisation of Rs 2,56,310 crore and a P\/E of 87.63 against an industry P\/E of 37.65. Its FY26 revenue rose 14.0% and net profit rose 17.2%, with return on equity at 15.32%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.\"}},{\"@type\":\"Question\",\"name\":\"Are these 25 percent quarterly revenue growth stocks expensive right now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Valuations vary across the group. Bank of Maharashtra trades at a P\/E of 7.77, Cholamandalam Investment and Finance trades at a P\/E of 22.04, Divi's Laboratories trades at a P\/E of 87.63, KFin Technologies trades at a P\/E of 42.76, Uno Minda trades at a P\/E of 49.04, against industry multiples ranging from 11.45 to 42.66. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.\"}},{\"@type\":\"Question\",\"name\":\"Which of these 25 percent quarterly revenue growth stocks pay a dividend?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dividend yields on this list are Bank of Maharashtra 1.48%, Cholamandalam Investment and Finance 0.12%, Divi's Laboratories 0.31%, KFin Technologies 1.39%, Uno Minda 0.24%. Yields are modest across the group, so most investors look at these stocks for growth in earnings rather than for income, and payouts can change with company profits.\"}},{\"@type\":\"Question\",\"name\":\"Which stock on this list has the highest return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Bank of Maharashtra has the highest ROE on this list at 22.53%, followed by KFin Technologies at 21.47% and Cholamandalam Investment and Finance at 18.02%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in 25 percent quarterly revenue growth stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are funding costs at the lender, one very high valuation and asset quality at the bank. On this list, Divi's Laboratories trades at the highest P\/E of 87.63, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.\"}},{\"@type\":\"Question\",\"name\":\"How can I invest in 25 percent quarterly revenue growth stocks in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P\/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Five 25 percent quarterly revenue growth stocks on the November 2026 watchlist with FY26 growth, valuation, ROE, shareholding and risks for BoM, Cholamandalam, Divi&#8217;s Labs, KFin Technologies and Uno Minda.<\/p>\n","protected":false},"author":35,"featured_media":343810,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[22236,717,457,11134,20376],"class_list":["post-343811","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-25-percent-quarterly-revenue-growth-stocks","tag-bank-of-maharashtra","tag-divis-laboratories","tag-kfin-technologies","tag-revenue-growth-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["343810"],"rank_math_title":["25 Percent Quarterly Revenue Growth Stocks to Buy in Nov 2026"],"rank_math_description":["25 Percent Quarterly Revenue Growth stocks to buy in November 2026: BoM, Cholamandalam and Divi's Labs, with FY26 growth, valuation, ROE and key risks for each."],"rank_math_focus_keyword":["25 percent quarterly revenue growth stocks to buy"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/25-percent-quarterly-revenue-growth-stocks-to-buy-in-november-2026-5-names-on.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/343811","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=343811"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/343811\/revisions"}],"predecessor-version":[{"id":343812,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/343811\/revisions\/343812"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/343810"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=343811"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=343811"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=343811"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}